LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with ...
Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果